Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer	Metastatic Castration-resistant Prostate Cancer	Not yet recruiting	Phase 2	2026-09-16		NCT07608718

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Pedro Barata, MD, MSc	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center	Cleveland	United States	13

Clinical trials